Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does tuberculosis increase HIV load?

John H Day1, Alison D Grant, Katherine L Fielding

  • 1London School of Hygiene and Tropical Medicine, London, United Kingdom.

The Journal of Infectious Diseases
|October 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness analysis of implementing a medication monitor and differentiated care approach among people with TB in South Africa.

BMC public health·2026
Same author

Longitudinal serological detection of exposure to SARS-CoV-2 in a cohort of pregnant women in Malawi: a secondary analysis from a randomised controlled trial.

BMJ open·2026
Same author

Within-household transmission risk of pulmonary tuberculosis in the era of universal antiretroviral therapy.

medRxiv : the preprint server for health sciences·2026
Same author

The role of interferon-gamma release assays in tuberculosis vaccine trials: strengths, limitations, and implications beyond trial design.

Vaccine·2026
Same author

Inclusion of young adolescents in policy development for new tuberculosis vaccines.

The Lancet. Global health·2026
Same author

Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Tuberculosis (TB) may not significantly worsen human immunodeficiency virus (HIV) progression. Higher baseline HIV load, not TB itself, likely drives poorer outcomes. TB prevention is crucial for reducing HIV-related deaths.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • The impact of tuberculosis (TB) on human immunodeficiency virus (HIV) disease progression remains unclear.
  • Understanding this interaction is critical for managing co-infected individuals.

Purpose of the Study:

  • To investigate the effect of tuberculosis episodes on HIV disease progression in adults.
  • To determine if TB itself, or pre-existing factors, contribute to poorer HIV outcomes.

Main Methods:

  • An observational cohort study was conducted in South Africa involving HIV-infected adults.
  • HIV viral load was compared between individuals with TB (n=30) and matched controls (n=56).
  • Linear regression modeling controlled for confounding factors like baseline CD4 count and HIV stage.

Related Experiment Videos

Main Results:

  • Individuals with TB had higher baseline and final HIV viral loads compared to controls.
  • After adjustments, the difference in final HIV load between groups was small (0.24 log10 copies/mL).
  • This adjusted increase in HIV load was not statistically significant (P=.06).

Conclusions:

  • Pre-existing high HIV viral load, rather than TB, may be the primary driver of poor prognosis in co-infected individuals.
  • While TB episodes showed a small, non-clinically significant increase in HIV load, TB prevention remains vital.
  • Antiretroviral therapy is essential for improving survival in individuals with HIV disease.